XML 16 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 67,941,337 $ 250,728,118
Short-term investments 326,999,236 160,914,935
Accounts receivable 4,770,773 18,559,967
Accounts receivable from affiliated entities 2,354,316 503,782
Prepaid expenses and other current assets 85,331,311 40,357,456
Prepaid expenses and other current assets from affiliated entities 0 106,432
Total current assets 487,396,973 471,170,690
Fixed assets, net 17,579,013 11,348,144
Investment in affiliated entity 3,886,710 4,460,366
Investment in Geneos 0 434,387
Intangible assets, net 2,753,126 3,146,770
Goodwill 10,513,371 10,513,371
Operating lease right-of-use assets 11,878,236 12,741,296
Other assets 1,755,083 25,957,448
Total assets 535,762,512 539,772,472
Current liabilities:    
Accounts payable and accrued expenses 28,654,864 21,203,808
Accounts payable and accrued expenses due to affiliated entities 491,645 642,969
Accrued clinical trial expenses 13,618,825 9,950,345
Deferred revenue 77,878 46,628
Operating lease liability 2,536,399 2,329,394
Grant funding liability 5,964,931 7,474,310
Grant funding liability from affiliated entity 31,250 58,500
Total current liabilities 51,375,792 41,705,954
Deferred revenue, net of current portion 68,075 79,214
Operating lease liability, net of current portion 16,133,245 18,063,515
Deferred tax liabilities 32,046 32,046
Grant funding liability from affiliated entity, net of current portion 37,500 37,500
Other liabilities 64,141 57,663
Total liabilities 82,190,133 78,631,714
Stockholders’ equity:    
Preferred stock 0 0
Common stock 210,362 186,851
Additional paid-in capital 1,556,527,891 1,367,406,869
Accumulated deficit (1,102,907,942) (906,196,812)
Accumulated other comprehensive loss (257,932) (256,150)
Total Inovio Pharmaceuticals, Inc. stockholders’ equity 453,572,379 461,140,758
Total liabilities and stockholders’ equity 535,762,512 539,772,472
Convertible senior notes    
Current liabilities:    
Convertible debt 14,479,334 14,139,988
Convertible bonds    
Current liabilities:    
Convertible debt $ 0 $ 4,515,834